New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
07:21 EDTZMHZimmer sees FY13 adjusted EPS $5.65-$5.85, consensus $5.74
Sees FY13 revenue up 2.5%-4.5% on constant currency basis, consensus $4.63B. The Company estimates that foreign currency translation will decrease revenues by approximately 0.5% for the full year 2013, resulting in reported revenue growth between 2% and 4%. In 2013, the Company expects to continue global restructuring and transformation initiatives designed to streamline business operations and support functions. Savings from these initiatives will enable the Company to absorb the medical device excise tax, continue to support investments in innovation and commercialization of new products and technologies, expand global sales channels and drive sustained growth in earnings and cash flow. The programs to be completed in 2013 are expected to generate annualized pre-tax savings of more than $80 million, including $30 million to $40 million to be realized in 2013.
News For ZMH From The Last 14 Days
Check below for free stories on ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent ZMH news | >>
April 24, 2014
12:10 EDTZMHZimmer advances after agreeing to merge with competitor
Subscribe for More Information
12:00 EDTZMHZimmer rises 12.6%
Zimmer is up 12.6%, or $11.51, to $102.96
10:00 EDTZMHZimmer rises 15.7%
Zimmer is up 15.7%, or $14.36, to $105.81
09:00 EDTZMHZimmer rises 17%
Subscribe for More Information
08:59 EDTZMHOn The Fly: Pre-Market Movers
Subscribe for More Information
08:43 EDTZMHZimmer deal could pressure Stryker, Smith & Nephew to grow, says Wells Fargo
Subscribe for More Information
08:41 EDTZMHZimmer: Combined company will be supported by R&D spend capability of $360M
Return on invested capital from Biomet transaction expected to exceed cost of capital by the end of the year three, with enterprise return on invested capital expected to exceed weighted average cost of capital in year one. Zimmer said it is "quite confident" the transaction will be completed in time and will be consummated in 1Q15.
08:37 EDTZMHZimmer sees Q2 EPs $1.46-$1.49, consensus $1.56
08:36 EDTZMHZimmer to suspend share repuchase program to preserve funding for transaction
Subscribe for More Information
08:35 EDTZMHZimmer sees Q2 revenue growth of 2%-3%, consensus $1.21B
Subscribe for More Information
07:54 EDTZMHSmith & Nephew up 2% after peers Zimmer, Biomet merge
Subscribe for More Information
07:49 EDTZMHZimmer backs FY14 revenue growth of 3%-5%, consensus $4.8B
Subscribe for More Information
07:13 EDTZMHZimmer cuts FY14 EPS to $6.00-$6.20 from $6.10-$6.20, consensus $6.21
Subscribe for More Information
07:11 EDTZMHZimmer reports Q1 adjusted EPS $1.50, consensus $1.47
Subscribe for More Information
07:11 EDTZMHZimmer to combine with Biomet in transaction valued at $13.35B
Subscribe for More Information
April 21, 2014
10:01 EDTZMHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:35 EDTZMHZimmer upgraded to Buy from Hold at Cantor
Subscribe for More Information
April 15, 2014
09:23 EDTZMHBarclays medical supplies/devices analysts hold analyst/industry conference call
Subscribe for More Information
April 14, 2014
10:02 EDTZMHOn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
07:29 EDTZMHZimmer upgraded to Neutral from Reduce at SunTrust
SunTrust upgraded Zimmer to Neutral after its survey indicated ortho recon volumes remain strong. The firm raised its price target for shares to $93 from $83.
1 | 2 | all recent ZMH news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use